The invention relates to compounds of general formula (I): wherein R1,n,R2a,R2band R3 are as defined herein. The compounds are inhibitors of Bc1-2-associateddeath promoter (BAD)phosphorylation and have anti-apoptotic activity and are useful in thetreatment of cancer, particularlybreast cancer, endometrial cancer, ovarian cancer, liver cancer, colon cancer,prostate cancer or pancreaticcancer.